Home biotechs
 

Keywords :   


Tag: biotechs

The BBJ's Five Things: Dodd-Frank's sting; Roxbury retrofit; Biotech's slowdown; NFL looks to Boston

2015-02-10 16:43:10| Biotech - Topix.net

Small banks are losing market share at nearly twice the rate they were in the years prior to the passage of the federal Dodd-Frank Wall Street Reform and Consumer Protection Act, according to two Harvard researchers. As the BBJ's Greg Ryan reports, community banks, or banks with less than $10 billion in assets, lost 6 percent of their share of U.S. banking assets from mid-2006 through mid-2010 - sizeable but not major losses, according to a new study from Harvard's Mossavar-Rahmani Center for Business and Government.

Tags: to things boston nfl

 

Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

2015-01-23 12:56:24| Biotech - Topix.net

Each year analysts pick their favorite biotechs and identify which they feel have the most upside. On December 22, RBC Capital picked five small-cap biotechs for 2015.

Tags: top watch capitals rbc

 
 

Here's the five best-performing Mass. biotechs in 2014

2015-01-05 19:27:21| Biotech - Topix.net

No. 5: Merrimack Pharmaceuticals . Stock gain: 119 percent. Current market cap: $1.2 billion.

Tags: in mass biotechs

 

Alan Mendelson sees biotech's biggest risk - and it may surprise you

2014-12-30 15:10:33| Biotech - Topix.net

Pioneering biotech lawyer Alan Mendelson of Latham & Watkins: "I get turned on still by the number of companies I have where the scientists come in and they're going to change the world." Alan Mendelson started out as a lawyer looking to change the world through politics; instead, he's ended up in a role that has helped extend thousands of lives.

Tags: you may risk alan

 

2 Bay Area biotechs set to test IPO market: Virobay, Atara Biotherapeutics

2014-10-13 21:42:00| Biotech - Topix.net

Atara Biotherapeutics, led by Dr. Isaac Ciechanover, filed plans to raise up to $92 million this week in an IPO that was put off in July. The Bay Area's fourth-quarter IPO season swings back into action with a pair of biotech offerings this week from Atara Biotherapeutics and Virobay.

Tags: set area test market

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »